Guthrie Towanda Memorial Hospital
Guthrie Towanda Memorial Hospital was paid $192K by Medicaid between Oct 2019 and Dec 2020, across 50 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 18% of everything it billed.
TOWANDA, PA 18848
Next to other General Acute Care Hospital providers in Pennsylvania
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 400 | $8K | |
| 2020 | 7,309 | $184K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 18% | 501 | 480 | $35K |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 18% | 1,231 | 221 | $35K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 13% | 221 | 212 | $26K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 151 | 144 | $23K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 8.6% | 238 | 229 | $16K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.5% | 60 | 59 | $11K |
| 80053 | Comprehensive metabolic panel | 5.1% | 819 | 751 | $10K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.3% | 821 | 748 | $4K |
| 80061 | Lipid panel | 1.8% | 244 | 244 | $4K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.5% | 73 | 73 | $3K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.5% | 99 | 95 | $3K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 35 | 34 | $2K |
38 more codes
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 29 | $2K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 194 | $1K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 92 | $1K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 96 | $1K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 148 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 109 | $1K |
| 84484 | <1% | 124 | $1K | |
| 80050 | General health panel | <1% | 18 | $1K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 65 | $911.06 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 12 | $823.54 |
| 83880 | <1% | 39 | $811.61 | |
| 83690 | <1% | 159 | $729.74 | |
| 83605 | <1% | 103 | $626.45 | |
| 82150 | <1% | 126 | $603.44 | |
| 81003 | <1% | 261 | $585.21 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 66 | $520.16 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 29 | $464.07 |
| 36415 | Collection of venous blood by venipuncture | <1% | 632 | $458.00 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 26 | $439.23 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 54 | $410.53 |
| 85610 | <1% | 166 | $339.89 | |
| 71045 | Radiologic examination, chest; single view | <1% | 70 | $309.50 |
| 85730 | <1% | 58 | $265.92 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 16 | $255.20 |
| 81001 | <1% | 104 | $248.54 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 48 | $244.33 |
| 83735 | <1% | 60 | $237.27 | |
| 87040 | <1% | 17 | $228.54 | |
| 81025 | <1% | 50 | $218.26 | |
| 73030 | <1% | 14 | $216.96 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 21 | $156.54 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 28 | $150.00 |
| 84439 | <1% | 22 | $144.48 | |
| 73630 | <1% | 14 | $144.23 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 96 | $111.90 |
| 85027 | <1% | 15 | $99.52 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 14 | $11.35 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Corning Hospital | Corning, NY | $17.73M |
| Robert Packer Hospital | Sayre, PA | $13.81M |
| Robert Packer Hospital | Towanda, PA | $1.93M |
| Troy Community Hospital Incorporated | Troy, PA | $1.10M |
| Robert Packer Hospital | Towanda, PA | $816K |
| Robert Packer Hospital | Sayre, PA | $11K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.